A Study of Hormonal Therapy and Apalutamide With or Without Abiraterone Acetate and Prednisone in Newly Diagnosed Prostate Cancers
Condition: Prostate Cancer Interventions: Drug: Apalutamide; Drug: Abiraterone Acetate; Drug: Prednisone; Procedure: Radical Prostatectomy; Procedure: Extended Pelvic lymphadenectomy; Drug: GnRH agonist/antagonist Sponsors: Memorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Prednisone | Prostate Cancer | Research | Study